Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya

被引:24
作者
Haberer, Jessica E. [1 ,2 ]
Mugo, Nelly [3 ,4 ]
Bukusi, Elizabeth Ann [4 ,5 ]
Ngure, Kenneth [3 ,6 ]
Kiptinness, Catherine [3 ]
Oware, Kevin [5 ]
Garrison, Lindsey E. [1 ]
Musinguzi, Nicholas [7 ]
Pyra, Maria [8 ]
Valenzuela, Susie [4 ]
Thomas, Katherine K. [4 ]
Anderson, Peter L. [9 ]
Thirumurthy, Harsha [10 ,11 ]
Baeten, Jared M. [4 ,12 ,13 ,14 ]
机构
[1] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[3] Kenya Govt Med Res Ctr, Ctr Clin Res, Thika, Kenya
[4] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[5] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya
[6] Jomo Kenyatta Univ Agr & Technol, Dept Community Heath, Nairobi, Kenya
[7] Global Hlth Collaborat, Mbarara, Uganda
[8] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
[9] Univ Colorado, Dept Pharmaceut Sci, Denver, CO USA
[10] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA
[11] Univ Penn, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA
[12] Univ Washington, Dept Med, Seattle, WA 98195 USA
[13] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[14] Gilead Sci, HIV Clin Dev, Foster City, CA USA
关键词
PrEP; adherence; electronic monitoring; young women; sub-Saharan Africa; TENOFOVIR-DIPHOSPHATE; HIV-INFECTION; RISK; EMTRICITABINE; PREVENTION; SCALES;
D O I
10.1097/QAI.0000000000002876
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To present detailed analyses of long-term pre-exposure prophylaxis (PrEP) use and associated behaviors and perceptions among young Kenyan women. Design: Prospective, observational cohort. Methods: The Monitoring PrEP among Young Adult women Study involved 18 to 24-year-old women at high HIV risk initiating PrEP in Kisumu and Thika, Kenya. Visits for PrEP counseling and dispensing, HIV testing, and socio-behavioral data collection occurred at Month 1 and quarterly for 2 years. PrEP adherence was measured with pharmacy refill and real-time electronic monitoring, plus tenofovir diphosphate levels in 15% of participants. HIV risk behavior and perception were assessed by self-report in weekly short message service surveys from Months 6-24. Predictors of adherence were assessed with multivariable logistic regression analysis. Results: Three hundred forty-eight women (median age 21, VOICE risk score 7) were followed for 617 person-years. Pharmacy refills steadily declined from 100% (Month 0-1) to 54% (Months 22-24). Average electronically monitored adherence similarly declined from 65% (Month 0-1) to 15% (Months 22-24). Electronically monitored adherence had moderately high concordance with tenofovir diphosphate levels (67%). High average adherence (5+ doses/week) was seen at 385/1898 (20%) participant-visits and associated with low baseline VOICE risk score, >1 current sexual partner, <= 1-hour travel time to clinic, and the Kisumu site. short message service-reported behavior and risk perception were not associated with adherence. Four women acquired HIV (incidence 0.7/100 person-years). Conclusions: PrEP adherence was modest and declined over time. HIV risk was inconsistently associated with adherence; clinic access and site-level factors were also relevant. Relatively low HIV incidence suggests participants may have achieved protection through multiple strategies.
引用
收藏
页码:251 / 260
页数:10
相关论文
共 47 条
[1]   Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men [J].
Anderson, Peter L. ;
Glidden, David V. ;
Liu, Albert ;
Buchbinder, Susan ;
Lama, Javier R. ;
Vicente Guanira, Juan ;
McMahan, Vanessa ;
Bushman, Lane R. ;
Casapia, Martin ;
Montoya-Herrera, Orlando ;
Veloso, Valdilea G. ;
Mayer, Kenneth H. ;
Chariyalertsak, Suwat ;
Schechter, Mauro ;
Bekker, Linda-Gail ;
Kallas, Esper Georges ;
Grant, Robert M. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (151)
[2]  
[Anonymous], 2020, Preliminary KENPHIA 2018 Report
[3]   HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial [J].
Baeten, Jared M. ;
Donnell, Deborah ;
Gichangi, Peter B. ;
Heller, Kate B. ;
Hofmeyr, G. Justus ;
Kiarie, James ;
Mastro, Timothy D. ;
Morrison, Charles S. ;
Mugo, Nelly R. ;
Nanda, Kavita ;
Palanee-Phillips, Thesla ;
Pleaner, Melanie ;
Rees, Helen ;
Scoville, Caitlin W. ;
Shears, Kathleen ;
Steyn, Petrus S. ;
Taylor, Douglas ;
Thomas, Katherine K. ;
Welch, Julia D. ;
Justman, Jessica ;
Nhlabatsi, Zelda ;
Bukusi, Elizabeth A. ;
Onono, Maricianah ;
Louw, Cheryl ;
Bekker, Linda-Gail ;
Nair, Gonasagrie ;
Smit, Jennifer ;
Hofmeyr, G. Justus ;
Singata-Madliki, Mandisa ;
Smit, Edendale Jennifer ;
Palanee-Phillips, Thesla ;
Selepe, Raesibe Agnes Pearl ;
Sibiya, Sydney ;
Ahmed, Khatija ;
Kasaro, Margaret Phiri ;
Stringer, Jeffrey .
LANCET, 2019, 394 (10195) :303-313
[4]  
Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974
[5]   Practical and conceptual challenges in measuring antiretroviral adherence [J].
Berg, Karina M. ;
Arnsten, Julia H. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 :S79-S87
[6]   Developing scales to measure perceived HIV risk and vulnerability among Ethiopian women testing for HIV [J].
Bradley, Heather ;
Tsui, Amy ;
Hindin, Michelle ;
Kidanu, Aklilu ;
Gillespie, Duff .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2011, 23 (08) :1043-1052
[7]   Risk perceptions and their relation to risk behavior [J].
Brewer, NT ;
Weinstein, ND ;
Cuite, CL ;
Herrington, JE .
ANNALS OF BEHAVIORAL MEDICINE, 2004, 27 (02) :125-130
[8]  
Bronfenbrenner U., 1992, ANN CHILD DEV, P187
[9]   Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis [J].
Carroll, Jennifer J. ;
Heffron, Renee ;
Mugo, Nelly ;
Ngure, Kenneth ;
Ndase, Patrick ;
Asiimwe, Stephen ;
Celum, Connie ;
Baeten, Jared M. .
SEXUALLY TRANSMITTED DISEASES, 2016, 43 (08) :471-475
[10]   Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring [J].
Castillo-Mancilla, Jose R. ;
Haberer, Jessica E. .
CURRENT HIV/AIDS REPORTS, 2018, 15 (01) :49-59